TMS Documentation: Expert Perspectives

The CTMSS Insurance Committee presents: “TMS Documentation: Expert Perspectives”. In this panel discussion, we will discuss the range of approaches when it comes to documenting TMS sessions. We will explore how the documentation serves multiple purposes for different audiences: clinical and administrative staff, patients, payers and the court.

You’re invited to join the Clinical TMS Society for this installment of our Grand Rounds Webinar Series: TMS Documentation: Expert Perspectives featuring Insurance Committee Members Sam Huber, Shelly Lahn, Rebecca Allen, and Carlene MacMillan!

The CTMSS Insurance Committee presents: "TMS Documentation: Expert Perspectives". In this panel discussion, we will discuss the range of approaches when it comes to documenting TMS sessions. We will also explore how the documentation serves multiple purposes for different audiences: clinical and administrative staff, patients, payers, and the court.

At the end of this presentation, participants will be able to:

  1. describe the core elements of a TMS procedure note in order to adequately convey clinical information to others involved in the care of a patient.
  2. understand the range of approaches to documentation of TMS sessions and the benefits and limitations of each approach.
  3. develop an approach to documentation of TMS sessions for your practice that meets the expectations of relevant insurance plans and malpractice carriers.

This Grand Rounds Webinar will highly encourage audience participation! 

1 Hour CME Credit available

Date: January 9th, 2023 at 8 pm EST / 5 pm PST / 1 am GMT 

Format: Live Webinar

Cost: Members: $25 | Non-members $50 | Student Members FREE

Can't make this time and date? All Grand Rounds are recorded and available On-Demand to all registered attendees. Recordings are available Friday after the live event.


Panelists:

Sam Huber, MD, MS

Sam Huber

Dr. Huber is an experienced physician executive and clinical psychiatrist. He holds degrees from the University of Rochester, University of Rochester School of Medicine, and the Dartmouth Institute for Health Policy and Clinical Practice. He trained at Washington University in St. Louis and the White River Junction Vermont VA Medical Center. He has served as Medical Director for Inpatient Psychiatry, Medical Director for Interventional Psychiatry, and Associate Quality Officer at the University of Rochester Medical Center, Associate CMO for Patient Safety and Quality at Rochester Regional Health (Rochester, NY), and Chief Medical Officer for MultiCare Behavioral Health-MultiCare Health System (Tacoma, WA). He has clinical experience across the spectrum of acute services including short and long-term inpatient, emergency psychiatry, consultation/integrated care, neuromodulation (ECT, TMS) and adult ambulatory psychiatry. As Medical Director for Interventional Psychiatry, Dr. Huber partnered with multiple divisions and stakeholders to sustain a margin-positive ECT service and launch the Rochester region’s first TMS service within a health system.

Shelly Lahn, MBA

Shelly Lahn

Shelly Lahn is the CEO of Neuro Wellness TMS Centers of America where they specialize in transcranial magnetic stimulation (TMS).

  • CTMSS Insurance Committee member
  • National Ketamine Task Force member
  • Owner/Operator/Founder of Neuro Wellness Centers of America using Apollo TMS Machines

Rebecca Allen, MD, MPH

Rebecca Allen

Dr. Allen graduated with a B.A. in Psychology with honors from Stanford University. She attended Oregon Health and Science University for medical school where she also earned a Masters of Public Health in biostatistics and epidemiology. She completed psychiatry residency at the Harvard Longwood Psychiatry Residency Training Program, a joint program between Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and Massachusetts Mental Health Center. She served as Chief Resident of the psychiatry consult service at Beth Israel Deaconess Medical Center. She then went on to complete a 2-year fellowship in Neuropsychiatry at Brigham and Women’s Hospital. She has participated in research on sleep and memory consolidation, quality of life in multiple sclerosis, efficacy of different TMS protocols, EEG biomarkers of TMS response, the RECOVER VNS trial, and other projects. She has authored several papers.

Moderator:

Carlene MacMillan, MD

Carlene MacMillan

Dr. MacMillan is the Chief Medical officer at Osmind. Osmind is a technology platform that helps clinicians who provide breakthrough mental health treatments track outcomes and document interventions. She is the Co-Chair of the Clinical TMS Society Insurance Committee and on the Board of Directors of the Clinical TMS Society. She participates in neuromodulation clinical trials and post-marketing research. She completed her medical training at Harvard medical school and her adult psychiatry residency and child psychiatry fellowship at Massachusetts General Hospital and McLean Hospital.

When
January 9th, 2024 from  5:00 PM to  6:00 PM
Location
United States
Contact
Phone: info@clinicaltmssociety.org
Event Fee(s)
Fee Level
Webinar Registration | Non-Member $50.00